Featured on day 1 of WCT 2025, Creed Health held a specialist session ‘Introducing an innovation solution for chemical debridement – Debrichem’. Steven Jeffery and Andrew Sharpe discussed the development of a clinical pathway for the use of a novel chemical debridement solution as well as an ongoing randomised controlled trial on the efficacy and safety of this new technology.